The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention

Circulation: Cardiovascular Interventions

Volumn 5, Issue 4, 2012, Pages 515-522

  Ng, Martin K C ^a   Yong, Andy S C ^a,c   Ho, Michael ^c   Shah, Maulik G ^c   Chawantanpipat, Chirapan ^a   O'Connell, Rachel ^a   Keech, Anthony ^a   Kritharides, Leonard ^b   Fearon, William F ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Microcirculation; Microvessels; Myocardial infarction

Indexed keywords

CREATINE KINASE; TROPONIN I; TROPONIN T;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CLINICAL ARTICLE; COLLATERAL CIRCULATION; COMORBIDITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CORONARY STENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FRACTIONAL FLOW RESERVE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROCIRCULATION; MICROCIRCULATORY RESISTANCE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; VASCULAR RESISTANCE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 84868622243     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.112.969048     Document Type: Article

References (31)

1. American Heart Association. Angioplasty and cardiac revascularization statistics. American Heart Association's heart disease and stroke statistics-2011 update. American Heart Association Web site. http://circ.ahajournals.org/content/123/4/e18.full.pdf. Accessed July 14th, 2012.
2. Ganesha Babu G, Malcolm Walker J, Yellon DM, Hausenloy DJ. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J. 2011;32:23-31.
3. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; Courage Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Eng J Med. 2007;356:1503-1516.
4. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2008;71:318-324.
5. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005;26:2493-2519.
6. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011;364:453-464.
7. Hoole SP, White PA, Heck PM, Khan SN, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP. Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis. Coron Artery Dis. 2009;20:253-259.
8. Albertal M, Voskuil M, Piek JJ, de Bruyne B, Van Langenhove G, Kay PI, Costa MA, Boersma E, Beijsterveldt T, Sousa JE, Belardi JA, Serruys PW. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation. 2002;105:1573-1578.
9. Lerman A, Holmes DR, Herrmann J, Gersh BJ, Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J. 2007;28:788-797.
10. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 2010;3:602-610.
11. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003;107:3129-3132.
12. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113:2054-2061.
13. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;51:560-565.
14. Aarnoudse W, Fearon WF, Manoharan G, Geven M, van de Vosse F, Rutten M, De Bruyne B, Pijls NH. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation. 2004;110:2137-2142.
15. Cuisset T, Hamilos M, Melikian N, Wyffels E, Sarma J, Sarno G, Barbato E, Bartunek J, Wijns W, De Bruyne B. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J Am Coll Cardiol. 2008;51:1060-1065.
16. Yong ASC, Ng ACC, Brieger D, Lowe HC, Ng MKC, Kritharides L. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J. 2011;32:345-353.
17. Herrmann J, Von Birgelen C, Haude M, Volbracht L, Malyar N, Eggebrecht H, Konorza TF, Baumgart D, Erbel R. Prognostic implication of cardiac troponin T increase following stent implantation. Heart. 2002;87:549-553.
18. Ricchiuti V, Shear WS, Henry TD, Paulsen PR, Miller EA, Apple FS. Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty. Clin Chim Acta. 2000;302:161-170.
19. Thygesen K, Alpert JS, White HD. Joint Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653.
20. Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 1996;131:1097-1105.
21. Iuliano L, Pratico D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, Violi F. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol. 2001;37:76-80.
22. Mandadi VR, DeVoe MC, Ambrose JA, Prakash AM, Varshneya N, Gould RB, Nguyen TH, Geagea JP, Radojevic JA, Sehhat K, Barua RS. Predictors of troponin elevation after percutaneous coronary intervention. Am J Cardiol. 2004;93:747-750.
23. Yong ASC, Ho M, Shah MG, Ng MKC, Fearon WF. Coronary microcirculatory resistance is independent of epicardial stenosis. Circ Cardiovasc Interv. 2012;5:103-108.
24. Layland J, MacIsaac AI, Burns AT, Somaratne JB, Leitl G, Whitbourn RJ, Wilson AM. When collateral supply is accounted for epicardial stenosis does not increase microvascular resistance. Circ Cardiovasc Interv. 2012;5:97-102.
25. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000;101:604-610.
26. Yonetsu T, Kakuta T, Lee T, Takahashi K, Yamamoto G, Iesaka Y, Fujiwara H, Isobe M. Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation. Int J Cardiol. 2011;146:80-85.
27. Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B; Fractional Flow Reserve Post-Stent Registry I. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105:2950-2954.
28. Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J. 2004;25:1822-1828.
29. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, Dulak J. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis. 2006;187:26-30.
30. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation. 1999;99:2871-2875.
31. Testa L, Van Gaal WJ, Biondi Zoccai GG, Agostoni P, Latini RA, Bedogni F, Porto I, Banning AP. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. Q J Med. 2009;102:369-378.